[Management of abnormal uterine bleeding].
Bleeding disorders are one of the most frequent gynecological problems. The causes of bleeding disorders, and their frequency in particular, vary depending on the age of the woman affected. In premenopause and perimenopause, the most frequent causes are hormonal, in up to 90 % of cases, as well as organic changes in the uterus such as myomas, adenomyosis uteri, or endometrial polyps, in up to 70 % of cases. Coagulation defects cause increased bleeding, particularly in girls and young women, with no other recognizable cause. The treatment of bleeding disorders is causally based, although if the woman does not wish to have children, the therapeutic algorithm in many cases leads to similar symptomatic measures. The following therapeutic approaches, listed in order of increasing efficacy, are mainly used in the treatment of increased bleeding: gestagen, estrogen-gestagen combination, levonorgestrel (Mirena) and endometrial ablation or myoma enucleation, with comparable success rates, and finally hysterectomy. Embolization of the uterine artery in myomas or adenomyosis uteri, nonsteroidal anti-inflammatory drugs, and antifibrinolytic agents represent alternatives that may be useful in individual cases. The paper provides an overview of the various causes, useful diagnostic measures, and treatment options in uterine bleeding disorders.
Gaetje
R
R
Klinik für Gynäkologie und Geburtshilfe, Johann Wolfgang Goethe-Universität, Frankfurt. Gaetje@em.uni-frankfurt.de
Scharl
A
A
Kaufmann
M
M
Ahr
A
A
D000465:Algorithms; D017115:Catheter Ablation; D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D004621:Embolization, Therapeutic; D004717:Endometrium / Q000473:pathology; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000627:therapeutic use; D008593:Menopause; D014592:Uterine Hemorrhage / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*
D003271:Contraceptive Agents, Female; D016912:Levonorgestrel